Protective effects of Andrographis paniculata Nees on post-infarction myocardium in experimental dogs

Abstract

One hour after the development of myocardial infarction by formation of thrombus, watery extract of Andrographis paniculata Nees (APN) was injected intravenously to 7 dogs for observing the protective effect of this drug on ischemic myocardium. 6 dogs served as control group. In the treated group PGI₂ increased remarkably, synthesis of TXA₂ was inhibited, cAMP in platelets was elevated, CK-MB peak was lowered and appeared earlier, ELT was shortened, release of platelet ß-GT was decreased, platelet maximum aggregation rate was inhibited, the size of ischemie area recorded by epicardial ECG was reduced, the amplitude of ST segment elevation was lower than that in the control group, Q wave appeared in only one dog. Pathologically, the myocardial structure surrounding the initially appearing ischemie area, i.e., the reversiblely damaged area, became relatively normal, while the degree of myocardial degeneration and necrosis in the central part of the ischemie area was mild. These data suggest that APN may limit the expansion of ischemie focus, exert marked protective effect on reversibly ischemie myocardium and demonstrate a weak fibrinolytic action.

Keywords

Chinese medicinal herb / Andrographis paniculata Nees / postmyocardial infarction / protective effect

References

[1] ZhaoHY, et al.. Antithrombotic effects of a Chinese medicinal herb for prevention of myocardial in farction. MMW, 1990, 132: 131-6

[2] 1989;9:540–2.

[3] FangWY, et al.. Study on experimental model of coronary artery thrombogenesis and acute myocardial infarction. J Tongji Med Univ, 1989, 9: 117-20

[4] MehtaJ, et al.. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs. JAMA, 1983, 249: 2818-23

[5] BhatAM, et al.. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats. Am Heart J, 1989, 117: 799-803

[6] ChiarielloM, et al.. Reduction in infarct size by the prostacyclin analogue iloprost after experimental coronary artery occlusion-reperfusion. Am Heart J, 1988, 115: 499-504

[7] JamesWD, et al.. A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease. Am J Cardiol, 1989, 63: 1450-4

[8] KeleinHM, et al.. Treatment of reperfusion injury with intracoronary calcium channel antagonists and reduced coronary free calcium concentration in regionally ischemic, reperfused porcine hearts. J Am Coll Cardiol, 1989, 13: 1395-1395

[9] PackhamMA, et al.. Pharmacology of platelet-affecting dugs. Circulation, 1980, 62: V-26-41

[10] 1984; 4:246–8.

[11] 1984; 4:357–8.

[12] 1987; 18:27–8.

[13] GolinoP, et al.. Simultaneous administration of thromboxane A₂- and serotonin S₂-receptor antagonists markedly enhances thromtolysis and prevents or delays reocclusion after tissue type plasminogen activator in a canin model of coronary thrombosis. Circulation, 1989, 79: 911-9